05/30/23 4:30 PMNYSE : ZTS conferencesZoetis to Participate in the Stifel 2023 Jaws and Paws ConferenceZoetis Inc. will participate in the Stifel 2023 Jaws and Paws Conference on Wednesday, May 31, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately 13,800 employees.RHEA-AIneutral
05/25/23 7:30 AMNYSE : ZTS Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next DecadeZoetis Inc. is hosting an investor day at 9:00 a.m. ET today at the New York Stock Exchange, where the company will dive into its compelling growth ambitions, its innovative and robust R&D pipeline and its financial roadmap to continue delivering shareholder value, as it Shapes Animal Health for the Next Decade. During today’ s presentations, Chief Executive...RHEA-AIpositive
05/16/23 7:30 AMNYSE : ZTS acquisitionJAB’s Pet Insurance Platform Acquires Pumpkin, Expanding its Global Leadership in the Fast-Growing Pet Insurance IndustrySince Zoetis launched Pumpkin in 2020, it has grown to provide insurance to more than 65,000 pets across the United States. JAB’ s global pet insurance portfolio includes leading brands such as AKC, ASPCA, Figo, Pet Partners and Pets Plus Us in the United States and Canada, and Agila, Animal Friends, Assur O’ Poil, Everypaw and Pet Protect in the U.K. and Europe.RHEA-AIpositive
05/11/23 4:05 PMNYSE : ZTS dividendsearningsZoetis Declares Third Quarter 2023 DividendThe Board of Directors of Zoetis Inc. has declared a dividend of $0.375 per share for the third quarter of 2023. The dividend will be paid on Friday, September 1, 2023, to all holders of record of the Company’ s common stock as of the close of business on Friday, July 21, 2023.. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately...RHEA-AIneutral
05/05/23 3:44 PMNYSE : ZTS fda approvalZoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in DogsZoetis Inc. today announced that the U.S. Food and Drug Administration has approved Librela™ for the control of pain associated with osteoarthritis in dogs. In studies, 40% of dogs have signs of OA. 3,4 With an estimated 86 million dogs living in the U.S. households, a high percentage of dogs are likely experiencing OA pain. 5 OA does not only impact older dogs– it...RHEA-AIneutral
05/04/23 7:00 AMNYSE : ZTS earningsZoetis Announces First Quarter 2023 Results“Today, we reported solid first-quarter results of 4% operational growth in revenue, as expected, based on our diverse portfolio and strength in international markets,” said Kristin Peck, Chief Executive Officer of Zoetis.“ Our International segment led the way, growing revenue 10% operationally, and was partially offset by a decline of 1% in the U.S. Our livestock...RHEA-AIneutral
05/01/23 8:30 AMNYSE : ZTS Zoetis Announces Date for 2023 Investor DayZoetis Inc. will host an Investor Day on Thursday, May 25, 2023, at the New York Stock Exchange featuring Kristin Peck, Chief Executive Officer; Wetteny Joseph, Chief Financial Officer; Robert Polzer, Ph.D., President of Research and Development; and other members of the Zoetis executive team. Zoetis will provide an update on the company’ s strategy to deliver...RHEA-AIneutral
04/05/23 8:00 AMNYSE : ZTS Zoetis Foundation Announces First Round of 2023 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Well-beingToday, the Zoetis Foundation announced that it will distribute $5.3 million during its first round of 2023 grants, supporting 21 initiatives impacting 15 countries to help enable thriving professions and livelihoods for livestock farmers and veterinary professionals, as well as relief efforts for those impacted by the earthquake in Türkiye.RHEA-AIpositive
03/30/23 8:30 AMNYSE : ZTS conferencesearningsZoetis to Host Webcast and Conference Call on First Quarter 2023 Financial ResultsZoetis Inc. will host a webcast and conference call at 8:30 a.m. on Thursday, May 4, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2023 financial results and respond to questions from financial analysts during the call. A Fortune 500 company, Zoetis generated...RHEA-AIneutral
03/13/23 8:00 AMNYSE : ZTS Zoetis Named One of the World’s Most Ethical Companies by EthisphereZoetis Inc. has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’ s Most Ethical Companies. “We are truly honored to be recognized by Ethisphere on their prestigious World’ s Most Ethical Companies list,” said Kristin Peck, CEO of Zoetis.“ Our culture is firmly grounded in our...RHEA-AIvery positive